TrialInternational journal of chronic obstructive pulmonary disease2016

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk.

Henry Covelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.